Financials

  • Market Capitalization 1.5209 M
  • Employee 17
  • Founded 1988
  • CEO David A. Dodd
  • Website www.geovax.com
  • Headquarter Delaware, United States
  • FIGI BBG000BGGJD8
  • Industry Technology
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.51
市销率
3.24

GeoVax Labs Inc

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated.

新闻